Background: Many factors, including molecular ones, were demonstrated to be associated with long-term prognosis of hepatocellular carcinoma (HCC). Thus far, the expression and clinicopathologic and prognostic significance of the carboxyl terminus of Hsp70-interacting protein (CHIP) in B-type hepatitis virus (HBV)related HCC remain unknown. Materials and Methods: CHIP expression was detected by immunohistochemical staining of surgical samples from 79 patients with HCC with HBsAg positivity. In addition, correlations with clinicopathologic parameters and patient survival were evaluated. Results: It was found that positive CHIP staining was observed in tumor, but not non-tumor, tissues. High expression of CHIP was significantly related to larger tumor size, with marginally significant associations noted for presence of portal vein invasion and higher serum a-fetoprotein level. In addition, univariate analysis showed that high CHIP expression was a powerful predictor for dismal overall and disease-free survival. However, independent prognostic implications of CHIP were not proven in multivariate Cox regression test. Conclusions: CHIP is overexpressed in HBV-related HCC and is associated with unfavorable biological behavior as well as poor prognosis. However, its prognostic role needs to be further validated.
Introduction
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal malignancy (Parkin et al., 1993; Pisani et al., 1999; Parkin et al., 2005) , that is largely associated with chronic B-type hepatitis (HBV) infection (El-Serag, 2011), worldwide. Thus far, it has been well known that HCC carries poor prognosis, although some favorable results have been reported in selected patients (Poon et al., 2001; Shimozawa et al., 2004; Verhoef et al., 2004) . Therefore, prognostic indicators of HCC were long of interest. It was summarized that many clinicopathologic parameters were predictive for long-term outcome of HCC (Tandon et al., 2009) . Recently, more and more alterations in genes/ proteins that are involved in cell phenotypes, such as expression pattern and methylation, have been found to be associated with prognosis of this neoplasm (Mínguez et al., 2011) . However, further evidence remains to be accumulated.
Carboxyl terminus of Hsp70-interacting protein (CHIP) that was first cloned in human heart (Ballinger et al., 1999) , has been indicated to play important biological roles in several types of malignant neoplasm, including RESEARCH ARTICLE
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Ye Jin 1& , Li Zhou 2& , Zhi-Yong Liang 3 , Ke-Min Jin 4 , Wei-Xun Zhou 3 , Bao-Cai Xing 4 * glioma, prostate cancer, gastric cancer, breast cancer and pancreatic cancer (Jang et al., 2011; Xu et al., 2011; Wang et al., 2013; Sarkar et al., 2014; Wang et al., 2014) . Interestingly, opposite results concerning CHIP were derived from different tumor types, i.e., functioning as a potential oncogene in glioma (Xu et al., 2011) and as a tumor repressor gene (TSG) in other cancers (Jang et al., 2011; Wang et al., 2013; Sarkar et al., 2014; Wang et al., 2014) . In human specimens, expression of CHIP was also shown to be a predictor of good or poor prognosis of different kinds of cancers (Jan et al., 2011; Liang et al., 2013; Wang et al., 2013; Wen et al., 2013; Wang et al., 2014) . Therefore, the biological effects and prognostic significance of CHIP might be tissue-type specific. However, expression, clinicopathologic and prognostic values of CHIP in HCC have not been studied.
In the present investigation, the authors aimed to address the issues in Chinese patients with HBV-related HCC.
Materials and Methods

Patients and specimens
Matched tumor and non-tumor tissue specimens were obtained from 79 patients with HBV-related HCC, defined as those with B-type hepatitis surface antigen (HBsAg) positivity. Patients underwent curative surgical resection in Department of Hepatobiliary Surgery I, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, China. There were 67 males and 12 females. The median age was 49 years (range: 28-73 years). Portal vein invasion (PVI), capsule formation, tumor number and size were first estimated by preoperative imaging examinations and demonstrated during surgery. Tumor differentiation grade, according to Edmondson-Steiner criteria (Edmondson et al., 1954) , was determined by postoperation histology. Patient clinicopathologic variables are summarized in Table 1 . The project was approved by the Institutional Ethics Committee.
Immunohistochemical staining
An anti-CHIP antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) was used for staining. Briefly, 4 µm-thick sections were first mounted, deparaffinized in xylene and rehydrated in graded ethanol. Antigen retrieval was performed using a high pressure method for 3 min. Slides were then incubated with 3% hydrogen peroxide for 10 min to eliminate endogenous peroxidase. Subsequently, slides were incubated overnight at 4°C with the primary antibody at a dilution of 1: 100. Pre-immune serum at the same dilution was used as the negative control. Following washing in phosphate buffered saline (PBS), horseradish peroxidase (HRP)-labeled secondary antibody was added for an incubation of 30 min. Diaminobenzidine was applied as a chromogen. Finally, slides were counterstained with hematoxylin.
Staining evaluation
Two independent pathologists who were blinded to clinicopathologic and follow-up data (Z.Y. L. and W.X. Z.) evaluated the slides, and discussed for a consensus when they were divergent. The positive signal was defined as brown coloration in tumor and non-tumor cells. Scoring of staining results was performed according to the standard previous used (Liang et al., 2013) .
Follow-up
Follow-up was performed for a total of 74 patients (median follow-up period: 28 months; range: 2 to 72 months). According to the follow-up data, 42 patients have died.
Statistical analyses
The Chi-square test was applied to analyze associations between CHIP expression and clinicopathologic factors. Patient survival was calculated using Kaplan-Meier staining signal was located in both cytoplasm and nucleus of HCC cells ( Figure 1B-E) . High CHIP expression was significantly associated with large tumor size (P<0.05; Table 1 ), and marginally linked to elevated serum AFP level and presence of PVI (0.05<P<0.10; Table 1 ). Other clinicopathologic parameters was not found to be related to CHIP expression (P>0.05; Table 1 ).
Prognostic factors of HBV-related HCC
Univariate analysis showed that high CHIP expression was associated with poor overall and disease-free survival in HBV-related HCC (P=0.024 and 0.043, respectively; Figure 2 and Table 2 ). In addition, Edmondson-Steiner grade, PVI, tumor number and size were also prognostic method and compared by log-rank test. Cox regression (Proportional hazard model) was used for multivariate analysis of prognostic markers. Statistical software package SPSS11.5 (SPSS Inc, Chicago, IL) was adopted for all analyses. Statistically significant P value was defined as less than 0.05.
Results
C H I P e x p r e s s i o n a n d a s s o c i a t i o n s w i t h clinicopathologic variables in HBV-related HCC High expression of CHIP was present in tumor tissues from 35 patients (44.3%) with HBV-related HCC, but absent in all the non-tumor tissues ( Figure 1A) . The brown for both overall and disease-free survival (P<0.05; Table 2 ), whereas other variables were not of statistical significance (P>0.05; Table 2 ). In multivariate Cox regression test, Edmondson-Steiner grade, tumor number and size were identified as independent prognostic indicators for overall and/or disease-free survival (P<0.05; Table 3 ). However, independent predictive values of CHIP expression for overall and disease-free survival were not proven (P>0.05; Table 3 ).
Discussion
CHIP is an E3 ligase that is combined with heat shock protein (HSP) 70 and 90 via the tetratricopeptide repeat (TPR) domain to mediate ubiquitin-dependent protein degradation (Ballinger et al., 1999; Connell et al., 2001) . Therefore, biological roles of CHIP in cells largely depend on its target proteins. So far, diverse effects of CHIP were observed in different malignancies, accompanied by identification of different targets, such as survivin, androgen receptor, NF-κB/p65, TRAF2 and EGFR (Jang et al., 2011; Xu et al., 2011; Wang et al., 2013; Sarkar et al., 2014; Wang et al., 2014) . On the other hand, clinicopathologic and prognostic implications of CHIP were also opposite in several types of cancer (Jan et al., 2011; Jang et al., 2011; Liang et al., 2013; Wang et al., 2013; Wen et al., 2013; Wang et al., 2014) . Thus, CHIP seems to be a protein that functions tissue-type specifically. However, the issues have not addressed in HCC. In view of the fact that HBV was the most frequent cause of HCC, the present work focused on HBV-related HCC. It was first found that CHIP expression was much higher in tumor tissues, in contrast to non-tumor ones ( Figure 1A) , indicating potential correlations of CHIP with HBV-related HCC. Surprisingly, our results showed positive nuclear staining of CHIP in tumor cells ( Figure  1D -E), different with previous reports presenting its cytoplasmic location (Jan et al., 2011; Jang et al., 2011; Xu et al., 2011; Liang et al., 2013; Wang et al., 2013; Wen et al., 2013; Wang et al., 2014) . The observation that HSP70, a protein that interacts with CHIP to form a complex, displayed nuclear staining in HCC tissues provides preliminary support (Effendi et al., 2010) . In the future, further validations and mechanism exploration are quite needed. Then, Chi-square test revealed that high CHIP expression was significantly associated with lager tumor size, and being of marginally significant relationship with presence of PVI and high serum AFP level. The link between tumor size and aggressive phenotypes in HCC was previously established (Kaibori et al., 2010; Kim et al., 2010) , whereas high serum AFP level and formation of PVI were also proven to contribute to progression and recurrence of the malignancy (Peng et al., 2004; Choi et al., 2011) . Therefore, CHIP seems to be involved in malignant biological behaviors and serve as an oncogene in HBV-related HCC. Of course, investigations on the detailed mechanisms are expected.
Similarly, the influence of CHIP on prognosis of a line of cancers was also suggested to be divergent (Jan et al., 2011; Liang et al., 2013; Wang et al., 2013; Wen et al., 2013; Wang et al., 2014) , because CHIP expression was associated with satisfactory outcome in gastric, pancreatic and breast cancers (Jan et al., 2011; Wang et al., 2013; Wang et al., 2014) , while related to gloomy survival in gallbladder and esophageal cancers (Liang et al., 2013; Wen et al., 2013) . However, no data derived from HCC. In the current investigation, we found that high expression of CHIP was predictive for poor survival in univariate analysis, together with some conventional clinicopathologic variables. Considering aforementioned results that CHIP expression was associated with malignant phenotypes, its prognostic implication might be easily understood. Therefore, CHIP might act as a potential biomarker for unfavorable prognosis of HBVrelated HCC. It is a pity that CHIP was not proven to be an independent prognostic factor in multivariate analysis. Thus, the value of this protein in prognosis prediction of HBV-related HCC remains to be evaluated in large-scale prospective studies.
Taken together, our data demonstrated that CHIP is overexpressed in HBV-related HCC and associated with unfavorable biological behaviors as well as poor prognosis.
